Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice

被引：14

作者：

Eagle, Kim A. ^{[1
]}

Cannom, David S. ^{[2
]}

Garcia, David A. ^{[3
]}

机构：

[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[2] Hosp Good Samaritan, Los Angeles, CA 90017 USA

[3] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2011年 / 124卷 / 01期

关键词：

Atrial fibrillation; Management; Treatment; RANDOMIZED CONTROLLED-TRIAL; VENTRICULAR SYSTOLIC DYSFUNCTION; MAINTAINING SINUS RHYTHM; HEART-FAILURE; ANTIARRHYTHMIC-DRUGS; STROKE PREVENTION; ORAL ANTICOAGULATION; CONSENSUS STATEMENT; AMERICAN-COLLEGE; FOLLOW-UP;

D O I：

10.1016/j.amjmed.2010.05.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation is a supraventricular tachyarrhythmia with significant consequences in terms of morbidity and mortality. In light of the limitations of available pharmacologic treatment options (suboptimal efficacy plus safety and tolerability issues), atrial fibrillation management should be individualized based on patient characteristics and comorbidities that could influence response to specific management approaches. The importance of adequate anticoagulation should not be overlooked. This review provides a practical guide for primary care physicians, internists, and cardiologists on current management strategies for atrial fibrillation, based on recent guidelines and current clinical data. (C) 2011 Elsevier Inc. All rights reserved. The American Journal of Medicine (2011) 124, 4-14

引用

页码：4 / 14

页数：11

共 91 条

[1] Oral anticoagulants versus antiplatelet therapy for preventing stoke in patients with non-valvular artial fibrillation and no history of stroke or transient ischemic attacks [J].